Advisory: Alerts on Genmab, Tempus entering into strategic collaboration agreement withdrawn
09/09/2019 14:29
Sept 9 (Reuters) - Please ignore alerts on Tempus entering
into strategic collaboration agreement with Genmab as they were
sent in error from a press release of an unrelated company.
STORY_NUMBER: FWN2600K5
STORY_DATE: 09/09/2019
STORY_TIME: 01:08:01
((gdynia.newsroom@thomsonreuters.com; +48 58 772 07 02;))
Recent news on Tempus Holdings
See all newsBrief: Tempus Says Loan Made Available To Co For Hk$11.25 Million
Brief: Tempus Says Listing Committee Decided To Cancel Co's Listing
Brief: Personalis And Tempus Announce Expanded Collaboration
Brief: Tempus Holdings Says Company And Liquidators Entered Exclusivity Agreement With Investor
Wall Street analysts bullish on genetic testing firm Tempus AI (updated)